Global Cardiovascular Drug Sales Market Report 2018

心血管疾患治療薬の世界市場:販売動向2018

◆タイトル:Global Cardiovascular Drug Sales Market Report 2018
◆商品コード:QYR80703061
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:113
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥856,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、心血管疾患治療薬の世界市場について調査・分析し、心血管疾患治療薬のメーカー別販売量、市場シェア分析、種類別販売分析(ヘパリン、クマジン、セクトラール、ゼベータ、ロプレッサー、トプロールXL、ノルバスク、ロットレル)、用途別販売分析(病院、診療所、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、心血管疾患治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・心血管疾患治療薬市場概要
・心血管疾患治療薬のメーカー別販売量・メーカー別シェア
・心血管疾患治療薬の世界市場:種類別販売量(ヘパリン、クマジン、セクトラール、ゼベータ、ロプレッサー、トプロールXL、ノルバスク、ロットレル)
・心血管疾患治療薬の世界市場:用途別販売量(病院、診療所、その他)
・心血管疾患治療薬の世界市場:地域別販売量・市場シェア
・心血管疾患治療薬の米国市場規模
・心血管疾患治療薬の中国市場規模
・心血管疾患治療薬の欧州市場規模
・心血管疾患治療薬の日本市場規模
・心血管疾患治療薬の東南アジア市場規模
・心血管疾患治療薬のインド市場規模
・心血管疾患治療薬のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・心血管疾患治療薬のコスト分析・価格動向
・心血管疾患治療薬の産業チェーン(サプライチェーン分析)
・心血管疾患治療薬のマーケティング戦略・販売チャネル、流通業者
・心血管疾患治療薬市場への影響要因分析
・心血管疾患治療薬の世界市場予測
・心血管疾患治療薬の米国市場予測
・心血管疾患治療薬の中国市場予測
・心血管疾患治療薬の欧州市場予測
・心血管疾患治療薬の日本市場予測
・心血管疾患治療薬の東南アジア市場予測
・心血管疾患治療薬のインド市場予測
・心血管疾患治療薬の種類別世界市場予測(ヘパリン、クマジン、セクトラール、ゼベータ、ロプレッサー、トプロールXL、ノルバスク、ロットレル)
・心血管疾患治療薬の用途別世界市場予測(病院、診療所、その他)
...

This report studies the global Cardiovascular Drug market status and forecast, categorizes the global Cardiovascular Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Cardiovascular disease (CVD) is a major cause of death in the U.S. and rest of the world. These diseases are primarily related with heart and blood vessels disorders, such asischemic heart disease, dyslipidemia, stroke, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease and others. These disorders are mainly reported due to obesity, high cholesterol, smoking, excessi alcohol, and poor lifestyle.
The hypertension segment recorded $64.9 billion in sales in 2009. By a large margin, hypertension is the largest segment within the cardiovascular market, driven by a large number of billion-dollar-plus therapies.
The global Cardiovascular Drug market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Portola
Sanofi

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
heparin
Coumadin
Sectral
Zebeta
Lopressor
Toprol XL
Norvasc
Lotrel
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Others

The study objectives of this report are:
To analyze and study the global Cardiovascular Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Cardiovascular Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cardiovascular Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Cardiovascular Drug Manufacturers
Cardiovascular Drug Distributors/Traders/Wholesalers
Cardiovascular Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Cardiovascular Drug market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Cardiovascular Drug Sales Market Report 2018
1 Cardiovascular Drug Market Overview
1.1 Product Overview and Scope of Cardiovascular Drug
1.2 Classification of Cardiovascular Drug by Product Category
1.2.1 Global Cardiovascular Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Cardiovascular Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 heparin
1.2.4 Coumadin
1.2.5 Sectral
1.2.6 Zebeta
1.2.7 Lopressor
1.2.8 Toprol XL
1.2.9 Norvasc
1.2.10 Lotrel
1.3 Global Cardiovascular Drug Market by Application/End Users
1.3.1 Global Cardiovascular Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Global Cardiovascular Drug Market by Region
1.4.1 Global Cardiovascular Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Cardiovascular Drug Status and Prospect (2013-2025)
1.4.3 Europe Cardiovascular Drug Status and Prospect (2013-2025)
1.4.4 China Cardiovascular Drug Status and Prospect (2013-2025)
1.4.5 Japan Cardiovascular Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Cardiovascular Drug Status and Prospect (2013-2025)
1.4.7 India Cardiovascular Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Cardiovascular Drug (2013-2025)
1.5.1 Global Cardiovascular Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Cardiovascular Drug Revenue and Growth Rate (2013-2025)

2 Global Cardiovascular Drug Competition by Players/Suppliers, Type and Application
2.1 Global Cardiovascular Drug Market Competition by Players/Suppliers
2.1.1 Global Cardiovascular Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Cardiovascular Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Cardiovascular Drug (Volume and Value) by Type
2.2.1 Global Cardiovascular Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Cardiovascular Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Cardiovascular Drug (Volume and Value) by Region
2.3.1 Global Cardiovascular Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Cardiovascular Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Cardiovascular Drug (Volume) by Application

3 United States Cardiovascular Drug (Volume, Value and Sales Price)
3.1 United States Cardiovascular Drug Sales and Value (2013-2018)
3.1.1 United States Cardiovascular Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Cardiovascular Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Cardiovascular Drug Sales Price Trend (2013-2018)
3.2 United States Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Cardiovascular Drug (Volume, Value and Sales Price)
4.1 Europe Cardiovascular Drug Sales and Value (2013-2018)
4.1.1 Europe Cardiovascular Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Cardiovascular Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Cardiovascular Drug Sales Price Trend (2013-2018)
4.2 Europe Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

5 China Cardiovascular Drug (Volume, Value and Sales Price)
5.1 China Cardiovascular Drug Sales and Value (2013-2018)
5.1.1 China Cardiovascular Drug Sales and Growth Rate (2013-2018)
5.1.2 China Cardiovascular Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Cardiovascular Drug Sales Price Trend (2013-2018)
5.2 China Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Cardiovascular Drug (Volume, Value and Sales Price)
6.1 Japan Cardiovascular Drug Sales and Value (2013-2018)
6.1.1 Japan Cardiovascular Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Cardiovascular Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Cardiovascular Drug Sales Price Trend (2013-2018)
6.2 Japan Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Cardiovascular Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Cardiovascular Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Cardiovascular Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Cardiovascular Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Cardiovascular Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

8 India Cardiovascular Drug (Volume, Value and Sales Price)
8.1 India Cardiovascular Drug Sales and Value (2013-2018)
8.1.1 India Cardiovascular Drug Sales and Growth Rate (2013-2018)
8.1.2 India Cardiovascular Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Cardiovascular Drug Sales Price Trend (2013-2018)
8.2 India Cardiovascular Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Cardiovascular Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Cardiovascular Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Cardiovascular Drug Players/Suppliers Profiles and Sales Data
9.1 Amgen
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Cardiovascular Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 AstraZeneca
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Cardiovascular Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 AstraZeneca Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bayer
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Cardiovascular Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bayer Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Bristol Myers Squibb and Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Cardiovascular Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Bristol Myers Squibb and Pfizer Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Daiichi Sankyo
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Cardiovascular Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Daiichi Sankyo Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Cardiovascular Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Johnson & Johnson Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Merck & Co.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Cardiovascular Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck & Co. Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Cardiovascular Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Cardiovascular Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pfizer Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Portola
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Cardiovascular Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Portola Cardiovascular Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Sanofi

10 Cardiovascular Drug Maufacturing Cost Analysis
10.1 Cardiovascular Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Cardiovascular Drug
10.3 Manufacturing Process Analysis of Cardiovascular Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Cardiovascular Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Cardiovascular Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Cardiovascular Drug Market Forecast (2018-2025)
14.1 Global Cardiovascular Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Cardiovascular Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Cardiovascular Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Cardiovascular Drug Price and Trend Forecast (2018-2025)
14.2 Global Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Cardiovascular Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Cardiovascular Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Cardiovascular Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Cardiovascular Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Cardiovascular Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Cardiovascular Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Cardiovascular Drug Price Forecast by Type (2018-2025)
14.4 Global Cardiovascular Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Cardiovascular Drug
Figure Global Cardiovascular Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Cardiovascular Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure heparin Product Picture
Figure Coumadin Product Picture
Figure Sectral Product Picture
Figure Zebeta Product Picture
Figure Lopressor Product Picture
Figure Toprol XL Product Picture
Figure Norvasc Product Picture
Figure Lotrel Product Picture
Figure Global Cardiovascular Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Cardiovascular Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Cardiovascular Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Cardiovascular Drug Sales Volume (K Pcs) (2013-2018)
Table Global Cardiovascular Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Cardiovascular Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Cardiovascular Drug Sales Share by Players/Suppliers
Figure 2017 Cardiovascular Drug Sales Share by Players/Suppliers
Figure Global Cardiovascular Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Cardiovascular Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Cardiovascular Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Cardiovascular Drug Revenue Share by Players
Table 2017 Global Cardiovascular Drug Revenue Share by Players
Table Global Cardiovascular Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Cardiovascular Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Cardiovascular Drug by Type (2013-2018)
Figure Global Cardiovascular Drug Sales Growth Rate by Type (2013-2018)
Table Global Cardiovascular Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Cardiovascular Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Cardiovascular Drug by Type (2013-2018)
Figure Global Cardiovascular Drug Revenue Growth Rate by Type (2013-2018)
Table Global Cardiovascular Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Cardiovascular Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Cardiovascular Drug by Region (2013-2018)
Figure Global Cardiovascular Drug Sales Growth Rate by Region in 2017
Table Global Cardiovascular Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Cardiovascular Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Cardiovascular Drug by Region (2013-2018)
Figure Global Cardiovascular Drug Revenue Growth Rate by Region in 2017
Table Global Cardiovascular Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Cardiovascular Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Cardiovascular Drug by Region (2013-2018)
Figure Global Cardiovascular Drug Revenue Market Share by Region in 2017
Table Global Cardiovascular Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Cardiovascular Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Cardiovascular Drug by Application (2013-2018)
Figure Global Cardiovascular Drug Sales Market Share by Application (2013-2018)
Figure United States Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table United States Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table United States Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Cardiovascular Drug Sales Volume Market Share by Application in 2017
Figure Europe Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table Europe Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table Europe Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Cardiovascular Drug Sales Volume Market Share by Application in 2017
Figure China Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure China Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table China Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure China Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table China Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure China Cardiovascular Drug Sales Volume Market Share by Application in 2017
Figure Japan Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table Japan Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table Japan Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Cardiovascular Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Cardiovascular Drug Sales Volume Market Share by Application in 2017
Figure India Cardiovascular Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Cardiovascular Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Cardiovascular Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Cardiovascular Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Cardiovascular Drug Sales Volume Market Share by Players (2013-2018)
Figure India Cardiovascular Drug Sales Volume Market Share by Players in 2017
Table India Cardiovascular Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Cardiovascular Drug Sales Volume Market Share by Type (2013-2018)
Figure India Cardiovascular Drug Sales Volume Market Share by Type in 2017
Table India Cardiovascular Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Cardiovascular Drug Sales Volume Market Share by Application (2013-2018)
Figure India Cardiovascular Drug Sales Volume Market Share by Application in 2017
Table Amgen Basic Information List
Table Amgen Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Amgen Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Amgen Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure AstraZeneca Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Bayer Basic Information List
Table Bayer Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Bayer Cardiovascular Drug Sales Global Market Share (2013-2018
Figure Bayer Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Bristol Myers Squibb and Pfizer Basic Information List
Table Bristol Myers Squibb and Pfizer Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol Myers Squibb and Pfizer Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Bristol Myers Squibb and Pfizer Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Bristol Myers Squibb and Pfizer Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Daiichi Sankyo Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Johnson & Johnson Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Cardiovascular Drug Sales Global Market Share (2013-2018
Figure Johnson & Johnson Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co. Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Merck & Co. Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Merck & Co. Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Novartis Cardiovascular Drug Sales Global Market Share (2013-2018
Figure Novartis Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Pfizer Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Pfizer Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Portola Basic Information List
Table Portola Cardiovascular Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Portola Cardiovascular Drug Sales Growth Rate (2013-2018)
Figure Portola Cardiovascular Drug Sales Global Market Share (2013-2018)
Figure Portola Cardiovascular Drug Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiovascular Drug
Figure Manufacturing Process Analysis of Cardiovascular Drug
Figure Cardiovascular Drug Industrial Chain Analysis
Table Raw Materials Sources of Cardiovascular Drug Major Players in 2017
Table Major Buyers of Cardiovascular Drug
Table Distributors/Traders List
Figure Global Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Cardiovascular Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Cardiovascular Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Cardiovascular Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Cardiovascular Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Cardiovascular Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Cardiovascular Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Cardiovascular Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Cardiovascular Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Cardiovascular Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Cardiovascular Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Cardiovascular Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Cardiovascular Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Cardiovascular Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Cardiovascular Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Cardiovascular Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Cardiovascular Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Cardiovascular Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

心血管疾患治療薬、ヘパリン、クマジン、セクトラール、ゼベータ、ロプレッサー、トプロールXL、ノルバスク、ロットレル、病院、診療所

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[心血管疾患治療薬の世界市場:販売動向2018] (Global Cardiovascular Drug Sales Market Report 2018 / QYR80703061)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆